Navigation Links
Immunotec Inc. announces retirement of President & CEO C.H. (Chuck) Roberts
Date:9/26/2007

VAUDREUIL-DORION, QC, Sept. 26 /PRNewswire-FirstCall/ - As Immunotec looks to the beginning of its twelfth year of operation, Co-founder, President and Chief Executive Officer, Mr. C.H. (Chuck) Roberts announces his retirement from his role as President. Mr. Roberts, a major shareholder in Immunotec, will continue his involvement with the corporation, both as an active member of the Board of Directors and as Co-founder, in a variety of public relations and sales support roles.

Mr. Roberts' wealth of business acumen and experience in heading successful Canadian companies, coupled with his sales vision for an innovative, research-based product called Immunocal/HMS 90, were behind the establishment of Immunotec Research Ltd. in 1996. His leadership and entrepreneurial expertise took a post-retirement venture from its roots as a small, Quebec-based enterprise to a major force within the North American network marketing industry. With sales exceeding $36.9 million dollars annually, Immunotec Inc. became a publicly-traded company in January 2007.

Mr. Roberts recognized that network marketing is about more than industry-leading products; his unwavering commitment to Immunotec's thousands of Distributors across Canada and the United States was the foundation for all of his business decisions throughout his presidency. Now, with the company firmly rooted, its longevity assured, and with an experienced and capable corporate team in place, Mr. Roberts steps back from his operational role to launch the company into its second phase, one of rapid expansion and growth.

The Board of Directors has approved the appointment of an incoming President and CEO and will make the formal announcement early next week.

About Immunotec

Immunotec operates out of a 37,000 square foot facility located in Vaudreuil-Dorion, Quebec, Canada as well as a distribution centre located in Swanton, Vermont, USA. Immunotec is engaged primarily in the development and mark
'/>"/>

SOURCE IMMUNOTEC INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Applied Biosystems, part of Life Technol...ovative life science research and discovery soluti...generation genomic analysis, the SOLiD™ Syst...the Year for 2008 by The Scientist, a leading scie...ustry. In making the announcement of the first-eve...
(Date:12/3/2008)... Dec. 3 ev3 Inc. (Nasdaq... today announced the appointment of John,L. Miclo... , Mr. Miclot is currently the president an...tely held nationwide provider of various home care...wound care, urology and respiratory,disorders. P...
(Date:12/3/2008).... 3 CeloNova BioSciences, Inc., an...hich it is commercializing the,CATANIA(TM) Corona...tent,system that has not had any stent thrombosis...le for purchase throughout Europe and now some Mid...expansion ongoing. Concurrently,CeloNova notes t...
(Date:12/3/2008)...Dennis will Outline How Technology Can Solve Press... , , KINGSTON, ON, Dec. 3 /PRNewswire/ - Dr...c. (PPI), is one of four leading experts speaking ...ge Conference underway in Poznan , Poland. Dr. Den...lems in the 20th Century and the role it will play...
Breaking Biology Technology: Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5ev3 Inc. Appoints John L. Miclot to Board of Directors 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3Leading Canadian Scientist to speak at UN Climate Change Conference 2
...sperson, one of the first rituals after shaking ha... or her card. In the business world, it is a refle...tualistic. , ,When I visited Japan a few years ag... the business card was so important to the Japanes..."may-shee). I learned to take a card carefully wit...
...the American Cancer Society, one in three people w... lifetime. In an effort to improve patient care an...cal Systems has developed innovative medical imagi...tter detect, diagnose and treat this deadly diseas...m GE include: two digital X-ray technologies desig...
...istics help manufactures manage some of the most c...stics networks in the world. The company will now ... help companies save millions of dollars with impr...der Logistics plans to target customers who choose...o build competitive operations with the industry,s...
...he pay differential between U.S. white collar work...ogrammer ,U.S.: $66,100 ,India: $10,000 , ,IT Mana...S.: $41,000 ,India: $5,000 , Not long ago, jobs le...manufacturing sector, as more and more factories p...an countries to cut costs. Not to mention all the ...
Other Biology Technology:Are You Your Business Card? 2Are You Your Business Card? 3GE Medicals Technologies Aid Battle Against Cancer 2GE Medicals Technologies Aid Battle Against Cancer 3Schneider Logistics Helps Manufacturers Secure Competitive Advantage 2Outsourcing Offshore - Wisconsin Companies Sending Work Abroad 2Outsourcing Offshore - Wisconsin Companies Sending Work Abroad 3
(Date:12/3/2008)...rst tandem mission between ERS-2 and Envisat last ...gain to help improve our understanding of the plan...at, the largest environmental satellite ever built...ments that provide high resolution images of the E...mages of the same site, slight alterations that ma...
(Date:12/3/2008)...e International Society for Stem Cell Research (IS...n of stem cell researchers, released new guideline...ctive stem cell therapies for patients. A Commenta...Clinical Translation of Stem Cells will be publish...em Cell , the official affiliated journal of the I...
(Date:12/3/2008)...ges in voltage that occur across the membrane of a...actor in the process by which these stem cells dif...ts University scientists. , Tufts doctoral stud...l Levin, and Chair of Biomedical Engineering David...paper "Membrane Potential Controls Adipogenic and...
(Date:12/3/2008)...ein and cereal grains produce an excess of acid in... weaken bones, according to a new study accepted f... of Clinical Endocrinology & Metabolism ( JCEM )....t of the diet, with a pill or through a diet rich ...nd strengthens skeletal health. , "Heredity, die...
Breaking Biology News(10 mins):ESA satellites flying in formation 2The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3New 'control knobs' for stem cells identified 2Calcium and vitamin D may not be the only protection against bone loss 2Conde Nast Media Group Announces Performance of Just Stand Up to be Fed Live from the Stage at FASHION ROCKS to ABC CBS and NBCs Simultaneous Broadca 25992 1Conde Nast Media Group Announces Performance of Just Stand Up to be Fed Live from the Stage at FASHION ROCKS to ABC CBS and NBCs Simultaneous Broadca 25992 2Conde Nast Media Group Announces Performance of Just Stand Up to be Fed Live from the Stage at FASHION ROCKS to ABC CBS and NBCs Simultaneous Broadca 25992 3Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 1Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 2Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 3Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 4Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 5Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 6Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 7Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 8Alexzas AZ 004 28Staccato 28R 29 Loxapine 29 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients 2937 9Dialysis Patient Citizens Welcomes New Members to Board of Directors 25988 1Dialysis Patient Citizens Welcomes New Members to Board of Directors 25988 2Dialysis Patient Citizens Welcomes New Members to Board of Directors 25988 3Gold Rush 21 The Monks go Gold and Platinum 25983 1
...ts at the University of Cincinnati (UC) have found...Malaysia -- still produce and sell consumer paints...appears in the early online edition of the journal...ber 2006. , The researchers say that this lead-...t, and a worldwide ban is urgently needed to avoid...
...allows scientists peering inside cells to discern ...tein they are studying has been developed and succ...Hughes Medical Institute,s Janelia Farm Research C...ional Institutes of Health and Florida State Unive...lution of conventional optical microscopes, which ...
...s, which prevent genes from producing harmful prot...mise to be more effective than conventional drugs,...s been slow. , Using gold nanoparticles combined w... have demonstrated a new method for developing ant...e agents. The findings will be published May 19 in...
...ations in the p53 tumor-suppressor gene, suggestin...in in defending against cancer. Similarly, roughly... protein occur in its DNA-binding core domain, poi...ivotal to its anti-cancer activity. , Clearly, a ... with DNA could provide important insights into pr...
Other Biology News:Study supports 'urgent' need for worldwide ban on lead-based paint 2Study supports 'urgent' need for worldwide ban on lead-based paint 3New light microscope sharpens scientists' focus 2New light microscope sharpens scientists' focus 3New light microscope sharpens scientists' focus 4New light microscope sharpens scientists' focus 5New light microscope sharpens scientists' focus 6Gold nanoparticles could improve antisense cancer drugs 2Structure determined for p53 tumor suppressor protein as bound to DNA for anti-cancer activity 2
...for Membrane Proteins ,Contains sufficient compon...tracts for 2-D gel analysis , ,Includes:, , Mem-P...(contains sufficient reagents for extracting 25 ce...0 mg each) Kit , 2-D PAGEprep Protein Clean-up an...
...r-fluorescein is a hairpin primer labeled with a f...on-fluorescent quencher) and a 3 single-stranded o...o the UniPrimer provided in the Amplifluor Univers...oncentration of 5.0 M.,Fluorescence (Linear:Hair...
Propidium Iodide from Calbiochem
Mouse monoclonal antibody raised against a partial recombinant EBI3. NCBI Entrez Gene ID = EBI3
Biology Products: